InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Kathiresan Sekar, Chief Executive Officer. Officer active across 1 companies, notably Verve Therapeutics, Inc.. In total, 9 filings have been logged. Total volume traded: €80k. The latest transaction was filed on 18 March 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
€180,15669,674 shares@ €2.585735.5% of flow
Common Stock
SEC:0000899243-22-011767:0·
€2,3001,870 shares@ €1.22981.4% of flow
Common Stock
SEC:0000899243-22-001203·
€2,3001,870 shares@ €1.22980.5% of flow
Common Stock
SEC:0000899243-22-001203:0·
€51,55342,000 shares@ €1.227531.5% of flow
Common Stock
SEC:0000899243-21-050032·
€51,55342,000 shares@ €1.227510.1% of flow
Common Stock
SEC:0000899243-21-050032:0·
€70,19257,000 shares@ €1.231442.8% of flow
Common Stock
SEC:0000899243-21-049812·
€70,19257,000 shares@ €1.231413.8% of flow
Common Stock
SEC:0000899243-21-049812:0·
€39,8742,500 shares@ €15.949624.3% of flow
Common Stock
SEC:0000899243-21-025070·
Ideal exit: 18 Mar 2022 (T+270)
€39,8742,500 shares@ €15.94967.8% of flow
Common Stock
SEC:0000899243-21-025070:0·
Ideal exit: 18 Mar 2022 (T+270)
9 of 9 declarations
About Kathiresan Sekar
Sekar Kathiresan is the Chief Executive Officer of Verve Therapeutics, Inc. In this role, he is responsible for the strategic and operational direction of the company. His expertise in biotechnology and ability to lead teams enable him to drive innovation and growth. He plays a key role in business development and stakeholder engagement.
